What is neonatal pneumonia?

neonatal pneumonia is pneumonia, which occurs in very young infants. This pulmonary disease can develop in infants aged 24 o'clock and often occurs partly due to abnormalities in the airways and lungs. Neonatal pneumonia is a significant cause of death in newborns; In deaths that occur in the first 30 days of life, pneumonia is a contributor to a factor of up to 25 percent of cases. Infants with pneumonia complicated infections by blood transmitted have a risk of mortality 10 percent and this risk three times if the child had low birth weight.

There are several risk factors for newborn pneumonia that may be present before birth. These include maternal fever, tenderness or uterine pain, urinary tract infection and fetal tachycardia. Symptoms that can be recorded at or shortly after birth include premature birth, overcast fetus and amniotic fluid and uterine membrane rupture before work starts. Another risk factorIt is a gestational disease of mothers wiinfective organism, which is known to be able to cross the placental barrier.

Newborn with pneumonia may have a number of different symptoms. These include abnormally high respiratory speeds, grunting during exhaling, yellow or green respiratory secretion, blood aspiration, deprivation of oxygen in certain tissues and colored skin, hair and nails. Newborns may also have fluctuating temperature, skin rash, jaundice, irregular heart rhythm and stretched abdomen.

Fast diagnosis and treatment of neonatal pneumonia is essential due to the high risk of mortality associated with this disease. Pneumonia can significantly change gas exchange in the lungs of newborns, which can lead to the deprivation of oxygen and compromise of metabolism of all types of cells in the body. Structural and immunological defense mechanisms are not fully shaped in newborns, which is all for Newbpossible to fight infection. In addition, there is an increased risk that the infection could spread from the lungs to other parts of the body.

The aims of the newborn treatment of pneumonia is to erad the infectious agent while protecting the child by providing respiratory support. However, certain risks are involved in the treatment, which must be minimized to ensure that the infant's lungs are not permanently damaged. The main risk of antimicrobial treatment is that antimicrobial drugs may temporarily worsen lung inflammation, which could increase the risk of permanent lung damage. Antimicrobial drugs are carefully selected to reduce this risk to minimize the dose required to combat the infection.

Antimicrobial drugs are the key to the successful treatment of this disease, but the drugs themselves cannot provide the child with adequate support. In addition to antimicrobial drugs, the child is provided by the oxygen source to make sure that he or she is not depressed by oxygen due to reduced lung function. Newborns can alsoGet blood transfusions and intravenous fluid to ensure adequate nutrition and blood oxygen capacity.